NCT02384616 (OXPED) is a NA clinical trial of Oxygen in Hyperoxia, sponsored by Walid HABRE.

Who is sponsoring NCT02384616?

NCT02384616 is sponsored by Walid HABRE.

What drugs are being tested in NCT02384616?

Interventions in NCT02384616: Oxygen.

Is NCT02384616 still recruiting?

NCT02384616 is currently completed. Last updated 6 August 2018.

Last reviewed 2018-08-06 · How we verify

NCT02384616: OXPED

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Intraoperative High Inspired OXygen Fraction on Pulmonary Function, Surgical Site Infection, Postoperative Nausea and Vomiting in PEDiatric Anesthesia, the OXPED Study

Completed NA Last updated 6 August 2018

What this trial tests

NA trial testing Oxygen in Hyperoxia in 58 participants. Completed in 1 June 2018.

Timeline

1 May 2015

Primary endpoint
1 June 2018

1 June 2018

Quick facts

Lead sponsor	Walid HABRE
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	basic science
Enrollment	58
Start date	1 May 2015
Primary completion	1 June 2018
Estimated completion	1 June 2018
Sites	1 location across Switzerland

Drugs / interventions tested

Oxygen — full drug profile →

Conditions studied

Hyperoxia — all drugs for Hyperoxia →

Sponsor

Walid HABRE

Who can join

Adults 4 to 16, any sex, with Hyperoxia. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Postoperative changes in lung volume in children receiving low (35%) or high (80%) intraoperative fraction of oxygen
Time frame: 24 hours
Measurement of end-expiratory lung volume by nitrogen wash-out technique
Postoperative changes in airway resistance in children receiving low (35%) or high (80%) intraoperative fraction of oxygen
Time frame: 24 hours
Measurement of airway resistance and respiratory system elastance by forced oscillation technique

Sponsor's own description

This study is aiming at assessing the effect of inspired oxygen fraction during general anesthesia on children's lung mechanics and volume. More specifically, the temporal change in end-expiratory lung volume (EELV) and respiratory system resistance and elastance during the perioperative period will be characterized in order to define the the effect of high inspired fraction of oxygen on lung function.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

High inspired oxygen fraction impairs lung volume and ventilation heterogeneity in healthy children: a double-blind randomised controlled trial.
Grandville B, Petak F, Albu G, Bayat S, et al · · 2019 · cited 27× · PMID 30916028 · DOI 10.1016/j.bja.2019.01.036

Verify or expand the search:

Other trials of Oxygen

Trials testing the same drug.

NCT06327373 — A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia · Phase 1, PHASE2 · not yet recruiting
NCT07464730 — Postoperative High-flow Nasal Oxygenation After High-risk Surgery in the Frail Adult · NA · not yet recruiting
NCT06498908 — Intracervical Balloon Placement With Nitrous Oxide Administration · Phase 3 · withdrawn
NCT07245628 — A Trial of Self-Adjusted Nitrous Versus Placebo During Office Vasectomy · EARLY_PHASE1 · recruiting
NCT07369232 — Cerebral Hemodynamic Effects of Oxygen and Antioxidants (CHEOXANT) · NA · recruiting

Other recruiting trials for Hyperoxia

Currently open trials in the same condition.

NCT05412810 — Oxidative Lipidomic Biomarkers During Mechanical Ventilation in Critically Ill Patients (OXY-BAL). · recruiting
NCT04413097 — Delayed Cord Clamping With Oxygen In Extremely Low Gestation Infants · NA · active not recruiting

Other Walid HABRE trials

Trials by the same sponsor.

NCT04188431 — Dexamethasone and Postoperative Bleeding Following Tonsillectomy in Children · Phase 4 · terminated
NCT04359407 — Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients · completed
NCT03151863 — Intranasal Dexmedetomidine for Procedural Pain Management in Elderly Adults in Palliative Care · Phase 3 · terminated
NCT02986269 — PSV on Ventilation Inhomogeneity and Lung Function in Patients Under SB Across LMA · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02384616 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Walid HABRE
Last refreshed: 6 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02384616.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing